Torthaí cuardaigh - Al Lin

  • 1 - 4 toradh as 4 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Evaluation of the Carcinogenic Potential of Roxadustat (FG-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in CD-1 Mice and Sprague Dawley Rats

    Evaluation of the Carcinogenic Potential of Roxadustat (FG-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in CD-1 Mice and Sprague Dawley Rats de réir James S. Beck, C Henschel, James Chou, Al Lin, Ughetta del Balzo

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease

    Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease de réir Qingjian Wang, William R. Usinger, Blake Nichols, Julia Gray, Leon Xu, Todd Seeley, Mitch Brenner, Guangjie Guo, Weihua Zhang, Noëlynn Oliver, Al Lin, David Yeowell

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

    HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques de réir Matthew M. Hsieh, Nathaniel S. Linde, Aisha Wynter, Mark E. Metzger, Carol Wong, Ingrid Langsetmo, Al Lin, Reginald D. Smith, Griffin P. Rodgers, Robert E. Donahue, Stephen J. Klaus, John F. Tisdale

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease

    Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease de réir Ughetta del Balzo, Pierre Signore, Gail Walkinshaw, Todd Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David Y. Liu, S J Klaus, Al Lin, Thomas B. Neff

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: